These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32776408)
1. Development of methylcellulose-based sustained-release dosage by semisolid extrusion additive manufacturing in drug delivery system. Cheng Y; Qin H; Acevedo NC; Shi X J Biomed Mater Res B Appl Biomater; 2021 Feb; 109(2):257-268. PubMed ID: 32776408 [TBL] [Abstract][Full Text] [Related]
2. 3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels. Cheng Y; Qin H; Acevedo NC; Jiang X; Shi X Int J Pharm; 2020 Dec; 591():119983. PubMed ID: 33065220 [TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation. Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795 [TBL] [Abstract][Full Text] [Related]
4. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets. Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019 [TBL] [Abstract][Full Text] [Related]
5. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Li Q; Guan X; Cui M; Zhu Z; Chen K; Wen H; Jia D; Hou J; Xu W; Yang X; Pan W Int J Pharm; 2018 Jan; 535(1-2):325-332. PubMed ID: 29051121 [TBL] [Abstract][Full Text] [Related]
6. A systematic approach to improve printability and cell viability of methylcellulose-based bioinks. Jergitsch M; Alluè-Mengual Z; Perez RA; Mateos-Timoneda MA Int J Biol Macromol; 2023 Dec; 253(Pt 7):127461. PubMed ID: 37852401 [TBL] [Abstract][Full Text] [Related]
7. An investigation into the effects of ink formulations of semi-solid extrusion 3D printing on the performance of printed solid dosage forms. Zhang B; Belton P; Teoh XY; Gleadall A; Bibb R; Qi S J Mater Chem B; 2023 Dec; 12(1):131-144. PubMed ID: 38050731 [TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing. Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925 [TBL] [Abstract][Full Text] [Related]
9. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing? Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815 [TBL] [Abstract][Full Text] [Related]
10. Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications. Aita IE; Breitkreutz J; Quodbach J Eur J Pharm Sci; 2020 Apr; 146():105266. PubMed ID: 32060006 [TBL] [Abstract][Full Text] [Related]
11. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament? Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R Molecules; 2021 May; 26(11):. PubMed ID: 34067434 [TBL] [Abstract][Full Text] [Related]
12. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction. Korte C; Quodbach J AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799 [TBL] [Abstract][Full Text] [Related]
13. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
14. Fabrication of Naftopidil-Loaded Tablets Using a Semisolid Extrusion-Type 3D Printer and the Characteristics of the Printed Hydrogel and Resulting Tablets. Tagami T; Ando M; Nagata N; Goto E; Yoshimura N; Takeuchi T; Noda T; Ozeki T J Pharm Sci; 2019 Feb; 108(2):907-913. PubMed ID: 30267782 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of Gastro-Floating Famotidine Tablets: Hydroxypropyl Methylcellulose-Based Semisolid Extrusion 3D Printing. Yang HS; Kim DW Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839639 [TBL] [Abstract][Full Text] [Related]
16. Extrudability analysis of drug loaded pastes for 3D printing of modified release tablets. Zidan A; Alayoubi A; Coburn J; Asfari S; Ghammraoui B; Cruz CN; Ashraf M Int J Pharm; 2019 Jan; 554():292-301. PubMed ID: 30439491 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907 [TBL] [Abstract][Full Text] [Related]
18. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
19. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery. Linares V; Casas M; Caraballo I Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539 [TBL] [Abstract][Full Text] [Related]
20. 'Tablet-in-Syringe': A Novel Dosing Mechanism for Dysphagic Patients Containing Fast-Disintegrating Tablets Fabricated Using Semisolid Extrusion 3D Printing. Panraksa P; Zhang B; Rachtanapun P; Jantanasakulwong K; Qi S; Jantrawut P Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]